Abstract:Purpose: Nerve allografts are highly antigenic and, thus, require the continuous use of immunosuppressive drugs. FK 506 was found to pre-vent rejection successfully. However, clinically neurotoxic complications have been noted in the central and peripheral nervous system although an increased rate of axonal regeneration has also been shown after nerve crush experiments. To investigate whether a possible regeneration pro-moting potency of FK 506 is determined via an influence on Schwann cells, Schwann cells were cultured from the sciatic nerve of the rat. Methods: The effect of 100 μM FK 506 administered daily on these cultures was assessed microscopically over a period of seven days and compared to an untreated control group of cultures. Additionally, the changes in intracellular calcium were recorded using a laser scanning microscope. In vivo regeneration of autologous rat sciatic nerve grafts was assessed clinically, histologically and morphometrically after two and six weeks. The animals received a daily administration of 0.6 mg FK 506/kg body weight, the control received saline. Results: In vitro FK 506 increased the Schwann cell number in culture significantly compared to non treated cultures, while the fibrocyte population was decreased. FK 506 caused a transient increase of intracellular calcium levels in cultured cells. In vivo, a significantly higher axon count was observed in the FK 506 treated grafts after two weeks regeneration compared with controls. Good regeneration was noted in all grafts after six weeks regeneration. Conclusions: The increased axon counts and decreased myelin debris in the FK 506 grafts after two weeks indicate an accelerated Wallerian degeneration and increased axon sprouting into the graft initially. The inhibition of calcineurin activity is not the mediator of the neurotrophic effect. FK 506 promotes axonal regeneration through binding to FKBP-12. The increase of intracellular calcium may induce Schwann cell pro-liferation via calmodulin. The therapeutic relevance for autologous nerve grafting, however, has to be defined in further studies.

Influence of FK506 Upon Migration of Human Fetal Schwann Cells in Vitro

Changes of Ultrastructure of Regenerative Nerve Fibers in Response to Application of Sustained Releasing Agent FK506

Stimulation of Schwann cell proliferation and axonal regeneration by FK 506

Effect Of combining FK506 and neurotrophins on neurite branching and elongation

Effect of FK506 in reducing scar formation by inducing fibroblast apoptosis after sciatic nerve injury in rats

Local FK506 dose‐dependent study using a novel three‐dimensional organotypic assay

FK506 contributes to peripheral nerve regeneration by inhibiting neuroinflammatory responses and promoting neuron survival

Promotion of Nerve Regeneration in Peripheral Nerve by Short-Course FK506 after End-to-side Neurorrhaphy.

[Study on the Effect of Immunosuppressive Agent FK506 on Growth and Migration of Lung Cancer Cell].

[Effect of FK506 on the Cavernous Nerve Regeneration after Injury].

An integrated microfluidic device for screening the effective concentration of locally applied tacrolimus for peripheral nerve regeneration

A new nerve engineering scaffold with FK506 for bridging large nerve defects

Effects of FK506 on Acrylamide-Induced Peripheral Nerve Injuries of Rats

Electrospun Polymer Fibers Modified with FK506 for the Long-Term Treatment of Acute Cardiac Allograft Rejection in a Heart Transplantation Model.

Rapamycin Promotes Schwann Cell Migration and Nerve Growth Factor Secretion.

Evaluation of PRGD/FK506/NGF Conduits for Peripheral Nerve Regeneration in Rats

In vitro effect of stromal cell derived factor-1 on the migration of neural stem cells

The Effect of Co-Transplantation of Nerve Fibroblasts and Schwann Cells on Peripheral Nerve Repair

Protection of FK506 Against Neuronal Apoptosis and Axonal Injury Following Experimental Diffuse Axonal Injury.

Efects of Novel Immunosuppressant FK506 on Dendritic Epidermal T Cells of Mice

Experimental research on T cell vaccination combined with FK506 against the rejection heterogenic transplantation on peripheral nerve